戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lysis (phosphoglycerate mutase, enolase, and pyruvate kinase).
2 KM2, the gene encoding the glycolytic enzyme pyruvate kinase.
3 n of other ChREBP target genes such as liver pyruvate kinase.
4  nonproliferating tumor cells require active pyruvate kinase.
5 tein kinase, while the tetramer is an active pyruvate kinase.
6 the splice isoforms of the glycolytic enzyme pyruvate kinase.
7 ress exclusively the embryonic M2 isoform of pyruvate kinase.
8 its alpha, beta(1), and beta(2) of plastidic pyruvate kinase.
9  of other known cytoplasmic proteins such as pyruvate kinase.
10 lation of the ChREBP target gene, liver-type pyruvate kinase.
11 he expression of the glucose-responsive gene pyruvate kinase.
12 ndicative for phosphorylation to MANT-ATP by pyruvate kinase.
13 rt of a larger complex of proteins including pyruvate kinase.
14 1,6-bisphosphate (Fru-1,6-BP) in human liver pyruvate kinase.
15  2) is an isoenzyme of the glycolytic enzyme pyruvate kinase.
16  synthase, SREBP1c, chREBP, glucokinase, and pyruvate kinase.
17 opsis genome encodes 14 putative isoforms of pyruvate kinases.
18 y, we demonstrate that the glycolytic enzyme pyruvate kinase 2 (PKM2) is required for sprouting angio
19 ntified the protein as a novel crab allergen pyruvate kinase 2.
20 ctrometry, we report isotopic resolution for pyruvate kinase (232 kDa) and beta-galactosidase (466 kD
21 complexes, such as phosporylase B (194 kDa), pyruvate kinase (232 kDa), and GroEL (801 kDa), to highl
22  permeability, and reduced concentrations of pyruvate kinase, a biomarker of pediatric gastrointestin
23 anslocation, we found that the M2 isoform of pyruvate kinase, a key enzyme in glycolysis, translocate
24 abnormally low levels of the red cell enzyme pyruvate kinase, a known cause of CNSHA.
25 to regulate target genes, such as liver-type pyruvate kinase, acetyl-CoA carboxylase 1, and fatty aci
26 e curves were classified to rapidly identify pyruvate kinase activators and inhibitors with a variety
27 gulates the conversion of protein kinase and pyruvate kinase activities.
28 a(1) subunit causes a reduction in plastidic pyruvate kinase activity and 60% reduction in seed oil c
29                           We found increased pyruvate kinase activity and a decreased ratio of reduce
30 r cells leads to a decrease in the levels of pyruvate kinase activity and an increase in the pyruvate
31 C-terminal 51 kDa truncation showed not only pyruvate kinase activity but also activation by aspartat
32 1 expression might be responsible for higher pyruvate kinase activity in db/db mouse retina.
33                              Thus, decreased pyruvate kinase activity in PKM2-expressing cells allows
34 with the tyrosine phosphopeptide affects the pyruvate kinase activity of PKM2.
35 e of the growth phenotype with pyruvate, and pyruvate kinase activity of purified recombinant PykM.
36                       This resulted not from pyruvate kinase activity per se but rather from the form
37  glycolytic enzyme pyruvate kinase M2 (PKAR; pyruvate kinase activity reporter), which multimerizes a
38 its BC cell survival in a dose-dependent but pyruvate kinase activity-independent manner.
39 hich hinders PKM2 tetramerization and blocks pyruvate kinase activity.
40 termediate phosphoenolpyruvate and decreased pyruvate kinase activity.
41 ported to have chaperone activity: catalase, pyruvate kinase, albumin, lysozyme, alpha-lactalbumin, a
42            We additionally demonstrated that pyruvate kinase also interacts with Kir6.2 subunits.
43 OK257 cells have high lactate dehydrogenase, pyruvate kinase and 3-hydroxyacyl-CoA dehydrogenase acti
44 ranscription of two divergent genes encoding pyruvate kinase and a putative SOS response nuclease, re
45                                Two proteins (pyruvate kinase and albumin) were inferred to be related
46                                        SFEC, pyruvate kinase and aldolase were co-localized by immuno
47 sphofructokinase, lactate dehydrogenase, and pyruvate kinase and analyzed by confocal microscopy.
48                                Surprisingly, pyruvate kinase and catalase were at least as effective
49 tasis, is most likely exerted by the enzymes pyruvate kinase and fructose bisphosphatase.
50 e in glycolytic flux, indicated by a rise in pyruvate kinase and lactate dehydrogenase activity, indi
51 ability because of reduced activity of liver pyruvate kinase and malic enzyme, which replenish pyruva
52 cycle flux, which together with increases of pyruvate kinase and phosphoenolpyruvate carboxylase acti
53 hat growth signals reciprocally regulate the pyruvate kinase and protein kinase activities of PKM2 by
54 udy suggests that the conversion between the pyruvate kinase and protein kinase activities of PKM2 ma
55 lated protein(s) regulates the conversion of pyruvate kinase and protein kinase of PKM2 by directly i
56 redictions correctly classify SNP effects in pyruvate kinase and suggest a genetic basis for strain-s
57 etrameric (streptavidin, concanavalin A, and pyruvate kinase), and pentameric (C-reactive protein) co
58 e, glyceraldehyde-3-phosphate dehydrogenase, pyruvate kinase, and glucose-6-phosphate isomerase showe
59      Glioma cells expressed both isoforms of pyruvate kinase, and inhibition of either glycolysis or
60 es that uses succinyl-coenzyme A synthetase, pyruvate kinase, and lactate dehydrogenase to couple the
61  example, hexokinase-2, phosphofructokinase, pyruvate kinase, and lactate dehydrogenase), while at th
62 tronic FV vector that expressed EGFP, R-type pyruvate kinase, and MGMTP140K, we were able to increase
63 igh activities of fructokinase, glucokinase, pyruvate kinase, and tricarboxylic acid cycle enzymes, i
64 ins, including Grp58, Grp78, alpha4-actinin, pyruvate kinase, and vimentin.
65                             Four isozymes of pyruvate kinase are differentially expressed in human ti
66  coupled with phosphoenol pyruvate (PEP) and pyruvate kinase as an ATP regeneration system.
67  on allosteric regulation in the human liver pyruvate kinase as obtained from full-protein alanine-sc
68 esis required PEP as the phosphate donor and pyruvate kinase as the catalyst.
69  two host glycolytic enzymes, aldolase A and pyruvate kinase, as well as lactate dehydrogenase, are e
70                                    Cytosolic pyruvate kinase (ATP:pyruvate 2-O-phosphotransferase, EC
71 f the allosteric regulation of rabbit muscle pyruvate kinase by Ala to demonstrate that this effector
72          One of these involved inhibition of pyruvate kinase by citrate, which accumulated and thereb
73 o the allosteric inhibition of rabbit muscle pyruvate kinase by phenylalanine.
74 The assay detected 75 nM ADP produced by the pyruvate kinase-catalyzed phosphorylation of pyruvate wi
75                    Therefore, the identified pyruvate kinase catalyzes a crucial step in the conversi
76                                    Plastidic pyruvate kinase catalyzes a highly regulated, ATP-produc
77                                              Pyruvate kinase catalyzes the final step in glycolysis a
78                                              Pyruvate kinase catalyzes the last and rate-limiting ste
79             The addition of this sequence to pyruvate kinase causes the cytoplasmic protein to be loc
80 ied including, LDH (Ra, Ch), G3PDH (Hu, Ch), pyruvate kinase (Ch), Annexin II (Ch), and protein disul
81 activities, decreased lactate dehydrogenase, pyruvate kinase, creatine kinase, and cytochrome c oxida
82                                              Pyruvate kinase deficiency (PKD) is an autosomal-recessi
83 ose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency also confer some degree of re
84                                              Pyruvate kinase deficiency is caused by mutations in PKL
85  and efficacy of mitapivat in 52 adults with pyruvate kinase deficiency who were not receiving red-ce
86 providing a potential cure for patients with pyruvate kinase deficiency, in vivo selection using foam
87 n the hemoglobin level in 50% of adults with pyruvate kinase deficiency, with a sustained response du
88 nother to cleave near a mutation that causes pyruvate kinase deficiency.
89  canine model of a severe erythroid disease, pyruvate kinase deficiency.
90 pients with chimerism using a mouse model of pyruvate kinase deficiency.
91 hen transplanted into minimally conditioned, pyruvate kinase-deficient recipients (CBA-Pk-1(slc)/Pk-1
92 levels, reducing the drive for production of pyruvate kinase-deficient red blood cells.
93 olic branch point and of its central enzyme, pyruvate kinase (DeltapykF), result in mutants with sign
94               We identified pykM as the only pyruvate kinase-encoding gene based on deficiency in act
95                     Paradoxically, decreased pyruvate kinase enzyme activity accompanies the expressi
96 ite/flux correlations suggest that plastidic pyruvate kinase exerts flux control and that the lipid/s
97  disrupted metabolic activity due to altered pyruvate kinase expression and/or alteration in the func
98 nproliferating tumor cells and no detectable pyruvate kinase expression in proliferating cells.
99                                    Switching pyruvate kinase expression to the M1 (adult) isoform lea
100 erase cleavage while preserving tumor type 2 pyruvate kinase expression.
101  using as a case study the rapid decrease in pyruvate kinase flux in yeast upon glucose removal.
102                               The isoform of pyruvate kinase from brain and muscle of mammals (M(1)-P
103                We report X-ray structures of pyruvate kinase from Leishmania mexicana (LmPYK) that ar
104 mparative molecular dynamics analysis of the pyruvate kinase from Leishmania mexicana is presented in
105     The catalytic activities of aldolase and pyruvate kinase functionally modulate K(ATP) channels in
106 or activation of transcription of the L-type pyruvate kinase gene and lipogenic enzyme genes, and (ii
107 (LDHA) expression, together with a switch in pyruvate kinase gene splicing from PKM2 to PKM1, marks t
108 sequestrin), glucose metabolism (hexokinase, pyruvate kinase, Glut4), oncogenesis (TGFbeta1, cathepsi
109 hydrogenase, myosin light chain, aldolase A, pyruvate kinase, glycogen phosphorylase, actinin, gamma-
110 ntial of this approach utilizing human liver pyruvate kinase (hLPYK) as a model.
111  glucose transporter-4, hexokinase-2, muscle-pyruvate kinase, hormone-sensitive lipase, and uncouplin
112                                We found that pyruvate kinase II (PyrKII) is essential for organelle m
113 phosphoenolpyruvate (PEP), the substrate for pyruvate kinase in cells, can act as a phosphate donor i
114 r, our study identifies an essential role of pyruvate kinase in preventing metabolic block during car
115 .2 protein similarly interact with GAPDH and pyruvate kinase in rat heart membrane fractions and that
116 oral, small-molecule allosteric activator of pyruvate kinase in red cells.
117                  We report that knockdown of pyruvate kinase in tumor cells leads to a decrease in th
118 es expression of the embryonic M2 isozyme of pyruvate kinase, in contrast to the M1 isozyme normally
119 APDH, triosephosphate isomerase, and M2-type pyruvate kinase increased approximately two- to threefol
120  is demonstrated by experiments in which the pyruvate kinase inhibitor, phenylalanine, is added to ce
121                            Thus, while yeast pyruvate kinase is covalently modified in response to gl
122 in a splice isoform of the glycolytic enzyme pyruvate kinase is necessary for the shift in cellular m
123 as glycolysis, where pathway outflow through pyruvate kinase is regulated by the concentration of a k
124                                              Pyruvate kinase is the only regulatory step of the commo
125 d the glycolytic activity of PKM2, the major pyruvate kinase isoenzyme known to regulate cellular glu
126 y a SiLAD proteomics analysis, we identified pyruvate kinase isoenzyme M2 (PKM2), a critical regulato
127          We find that a deficiency in the M2 pyruvate kinase isoform (PKM2) reduces the levels of met
128 , this is partly achieved through control of pyruvate kinase isoform expression.
129                                              Pyruvate kinase isoform M2 (PKM2) is a glycolysis enzyme
130                                              Pyruvate kinase isoform M2 (PKM2) is an enzyme-catalyzin
131                        It is long known that pyruvate kinase isoform M2 (PKM2) is released into the c
132       Here, we demonstrated that the nuclear pyruvate kinase isoform M2 (PKM2) levels were positively
133                                              Pyruvate kinase isoform M2 (PKM2) plays an important rol
134 s that promote the metabolic activity of the pyruvate kinase isoform PKM2, such as TEPP-46 and DASA-5
135                                The embryonic pyruvate kinase isoform, PKM2, is almost universally re-
136                             The influence of pyruvate kinase isoforms on tumor cells has been extensi
137                                          The pyruvate kinase isoforms PKM1 and PKM2 are alternatively
138 ed protein product (UNP) similar to enolase, pyruvate kinase, isoforms of creatine kinase, aldolase A
139                                     The main pyruvate kinase isozyme (Cdc19) is phosphorylated in res
140 ological activators of a tumor cell specific pyruvate kinase isozyme (PKM2) may be an approach for al
141                                        Human pyruvate kinase isozyme M2 (hPKM2) is expressed in early
142  glycolytic enzymes alpha-enolase (ENO1) and pyruvate kinase isozyme M2 (PKM2), were assessed for the
143 ng T-complex polypeptide 1 subunit zeta, and pyruvate kinase isozyme.
144                                The M1 and M2 pyruvate-kinase isozymes are expressed from a single gen
145                                     Although pyruvate kinase knockdown results in modest impairment o
146 is from both glucose and glutamine following pyruvate kinase knockdown.
147 ate-responsive element-binding protein-beta, pyruvate kinase L, SCD-1, and DGAT1, key transcriptional
148 h glucose and reduced the activity of L-type pyruvate kinase (L-PK) and TxNIP promoters, two well-cha
149 ciprocally regulate expression of the L-type pyruvate kinase (L-PK) gene by controlling the formation
150    Glucose-mediated activation of the L-type pyruvate kinase (L-PK) gene is repressed by cAMP, making
151 glucose-mediated induction of hepatic L-type pyruvate kinase (L-PK) gene transcription.
152    The initial 26 amino acids of human liver pyruvate kinase (L-PYK) are not present/observed in the
153 ize the regulatory properties of human liver pyruvate kinase (L-PYK), we have noted that the affinity
154 y metabolomics revealed that inactivation of pyruvate kinase leads to accumulation of phosphoenolpyru
155       We quantified gene copy numbers of the pyruvate kinase, liver, and red blood cell (PKLR) gene a
156 by its ability to bind the ChRE of the liver pyruvate kinase (LPK) gene.
157  splicing in VAChT-deficient mice, including pyruvate kinase M, a key enzyme involved in lactate meta
158  with allosteric regulation in rabbit muscle pyruvate kinase (M(1)-PYK).
159         Here, we assessed whether disrupting pyruvate kinase-M (Pkm), an enzyme that acts in the term
160            Although normal cells express the pyruvate kinase M1 isoform (PKM1), tumor cells predomina
161  human cancer cell lines and replace it with pyruvate kinase M1.
162 ET biosensors based on the glycolytic enzyme pyruvate kinase M2 (PKAR; pyruvate kinase activity repor
163 romote dimerization of the glycolytic enzyme pyruvate kinase M2 (PKM2) and enable its nuclear translo
164                             Here we identify pyruvate kinase M2 (PKM2) as a novel PTP1B substrate in
165                               In particular, pyruvate kinase M2 (PKM2) expression and activity were u
166 f CLL cells, indicated by down-regulation of pyruvate kinase M2 (PKM2) expression and activity, decre
167 , we identified exosome-mediated transfer of pyruvate kinase M2 (PKM2) from PCa cells into bone marro
168                                  The role of pyruvate kinase M2 (PKM2) in cell proliferation is contr
169         The former, in turn, was mediated by pyruvate kinase M2 (PKM2) interaction with soluble adeny
170                                              Pyruvate kinase M2 (PKM2) is a key enzyme for glycolysis
171                                              Pyruvate kinase M2 (PKM2) is a metabolic enzyme that pla
172                                              Pyruvate kinase M2 (PKM2) is also induced and interacts
173                               Tumor-specific pyruvate kinase M2 (PKM2) is essential for the Warburg e
174                                              Pyruvate kinase M2 (PKM2) is expressed at high levels du
175                               Tumor-specific pyruvate kinase M2 (PKM2) is instrumental in both aerobi
176                                The embryonic pyruvate kinase M2 (PKM2) isoform is highly expressed in
177 is mediated by inhibitory S-nitrosylation of pyruvate kinase M2 (PKM2) through a novel locus of regul
178 S caused inhibition of the glycolytic enzyme pyruvate kinase M2 (PKM2) through oxidation of Cys(358).
179                            The tumor form of pyruvate kinase M2 (PKM2) undergoes tyrosine phosphoryla
180                          Moreover, levels of pyruvate kinase M2 (PKM2) were increased in this model a
181                    Recent data indicate that pyruvate kinase M2 (PKM2), a glycolytic enzyme for Warbu
182                       Here, we show that the pyruvate kinase M2 (PKM2), a glycolytic enzyme required
183 ship of TG2 to a terminal glycolytic enzyme, pyruvate kinase M2 (PKM2), and found that PKM2 regulates
184  key glycolytic proteins, including enolase, pyruvate kinase M2 (PKM2), lactate dehydrogenase and mon
185 tic intrabody, intrabody 5 (IB5), recognized pyruvate kinase M2 (PKM2), which is expressed in cancer
186 ide evidence to support a novel role for the pyruvate kinase M2 (PKM2)-mediated Warburg effect, namel
187 ic glycolysis and tumor growth by inhibiting pyruvate kinase M2 (PKM2).
188 ypes of human tumor cells have overexpressed pyruvate kinase M2 (PKM2).
189 ng, as a model system, the glycolytic enzyme pyruvate kinase M2 (PKM2).
190 ylation at Y59, which interacts with nuclear pyruvate kinase M2 (PKM2).
191   Here we use short hairpin RNA to knockdown pyruvate kinase M2 expression in human cancer cell lines
192   In addition, loss of the glycolytic enzyme pyruvate kinase M2 impairs trabeculation.
193                                          The pyruvate kinase M2 isoform (PKM2) is expressed in cancer
194                 Very recently, we found that pyruvate kinase M2 isoform (PKM2) regulates visual funct
195 noma (HCC) through nuclear relocalization of pyruvate kinase M2 isoform (PKM2), a key regulator of th
196 oma (HCC) by maintaining low activity of the pyruvate kinase M2 isoform (PKM2), a key regulator of th
197 ncluding many metabolic proteins such as the pyruvate kinase M2 isoform (PKM2).
198                                        Tumor pyruvate kinase M2 isoform (tM2-PK), which is an isoform
199 s and remarkable downregulation of c-Myc and pyruvate kinase M2 isoform, the key glycolytic enzyme tr
200 IRT6 binds to and deacetylates nuclear PKM2 (pyruvate kinase M2) at the lysine 433 residue.
201             AR (androgen receptor) and PKM2 (pyruvate kinase M2) have key roles in these processes.
202 nometabolism, with increased cytosolic PKM2 (pyruvate kinase M2), phosphorylated PKM2, HIF-1alpha (hy
203  a Warburg effect, including cytosolic PKM2 (pyruvate kinase M2), phosphorylated PKM2, succinate, HIF
204                                 Importantly, pyruvate kinase M2, a fetal anabolic enzyme implicated i
205 ark cancer genes, including hexokinase 2 and pyruvate kinase M2.
206 lycolytic pathway, 6-phosphofructokinase and pyruvate kinase M2.
207 CC cells by targeting hexokinase-2 (Hk2) and pyruvate kinase-M2 (Pkm2).
208 acetylation and lysosomal degradation of the pyruvate kinase-M2 isoform (PKM2).
209               We show that the M2 isoform of pyruvate kinase (M2PYK) exists in equilibrium between mo
210 e for peptides from novel variants of muscle pyruvate kinase, malate dehydrogenase 1, glyceraldehyde-
211 se-transporter-1 mRNA, and of Hexokinase and Pyruvate-Kinase mRNAs, key regulators of glycolysis.
212 xpression to control alternative splicing of pyruvate kinase muscle (PKM) isoforms 1 and 2, resulting
213 Moreover, we show that the metabolic enzyme, pyruvate kinase muscle (PKM), interacts with sub-pools o
214 y in nucleus pulposus (NP) cells through the pyruvate kinase muscle (PKM)-2-Jumonji domain--containin
215                        The glycolytic enzyme Pyruvate Kinase Muscle 2 (PKM2) has described roles in r
216                                        Pkm2 (Pyruvate kinase muscle isoenzyme 2) is an isoenzyme of t
217 al proximity of Tnfalpha alleles depended on pyruvate kinase muscle isoform 2 (PKM2) and T-helper-ind
218 lar to cancer cells, photoreceptors maintain pyruvate kinase muscle isoform 2 (PKM2) expression, whic
219                                              Pyruvate kinase muscle isoform 2 (PKM2) is a key glycoly
220                                              Pyruvate kinase muscle isoform 2 (PKM2) is a key glycoly
221 otein), resulting in alternative splicing of pyruvate kinase muscle isoforms 1 and 2 (PKM1 and 2) and
222                JMJD5 interacts directly with pyruvate kinase muscle isozyme (PKM)2 to modulate metabo
223                                              Pyruvate kinase muscle isozyme 2 (PKM2) is a key regulat
224 ic reprogramming and IFN-gamma secretion via pyruvate kinase muscle isozyme 2 (PKM2) to accelerate at
225 n of hypoxia-inducible factor-1A and reduced pyruvate kinase muscle isozyme 2 activity, both key regu
226  vesicles regulate B-cell IgG production via pyruvate kinase muscle isozyme 2.
227 ncreased expression of the glycolytic enzyme pyruvate kinase muscle isozyme M2 and after KIR cross-li
228 utase 2, glycogen phosphorylase muscle form, pyruvate kinase muscle isozyme, beta-enolase and triosep
229  spots identified as glycogen phosphorylase, pyruvate kinase muscle isozyme, isoforms of creatine kin
230  glucose-6-phosphate dehyrogenase (G6PD) and pyruvate kinase muscle type 2 (PKM2) that facilitates vi
231  divided by CCS fwhm) of ~60 is obtained for pyruvate kinase (MW ~ 233 kDa); however, ion mobility re
232 NDP kinase to suppress anaerobic growth in a pyruvate kinase-negative E. coli mutant.
233 EGFR and that of a green fluorescent protein-pyruvate kinase-NLS reporter protein.
234 aliana) mutant (pkp1) deficient in plastidic pyruvate kinase (PK(p)) and unable to accumulate storage
235           While in both wild types plastidic pyruvate kinase (PK(p)) provides most of the pyruvate fo
236                Muller glia are deficient for pyruvate kinase (PK) and for aspartate/glutamate carrier
237 -opts the cellular glycolytic ATP-generating pyruvate kinase (PK) directly into the viral replicase c
238                                              Pyruvate kinase (PK) exists in M1 (PKM1) and M2 (PKM2) i
239 shows the critical role of glycolytic enzyme pyruvate kinase (PK) in directing metabolism of prolifer
240                                              Pyruvate kinase (PK) is the main "pacemaker" of the EDP,
241  carbon source but the lack of a functioning pyruvate kinase (PK) means that carbohydrates cannot be
242  of the low-activity (dimeric) M2 isoform of pyruvate kinase (PK) over its constitutively active spli
243                                  In mammals, pyruvate kinase (PK) plays a key role in regulating the
244 sing excess CTP instead of ATP as substrate, pyruvate kinase (PK), and firefly luciferase) to generat
245 duct generates the PKM1 and PKM2 isoforms of pyruvate kinase (PK), and PKM2 expression is closely lin
246  GAPDH, aldolase, phosphofructokinase (PFK), pyruvate kinase (PK), lactate dehydrogenase (LDH), carbo
247                      Luo et al. now identify pyruvate kinase (PK)-M2 as an intriguing new interacting
248 e, whereas another could involve reversal of pyruvate kinase (PK).
249 reen, we identified liver and red blood cell pyruvate kinase (PKLR) as a driver of metastatic liver c
250 ted Sites (BORIS) at the alternative exon of Pyruvate Kinase (PKM) is associated with cancer-specific
251 mely, the rate-limiting enzyme of glycolysis pyruvate kinase (PKM), which plays a critical role in ca
252 d decrease in the expression and activity of pyruvate kinase PKM2, a glycolytic enzyme that indirectl
253   We find that SHMT2 activity limits that of pyruvate kinase (PKM2) and reduces oxygen consumption, e
254 In this study, we identify the M2 isoform of pyruvate kinase (PKM2) as a critical target of the sirtu
255 phorylation of the tumor-specific isoform of pyruvate kinase (PKM2) at Y105, resulting in decreased e
256  Upregulation of the embryonic M2 isoform of pyruvate kinase (PKM2) emerges as a critical player in t
257  active tetramer and inactive dimer forms of pyruvate kinase (PKM2) in cancer cells, similar to the t
258                            The M2 isoform of pyruvate kinase (PKM2) promotes the metabolism of glucos
259 e we report that the embryonic M2 isoform of pyruvate kinase (PKM2), a key enzyme contributing to the
260 e M2 isoform of the tightly regulated enzyme pyruvate kinase (PKM2), which controls glycolytic flux,
261 dominance of expression of the M2 isoform of pyruvate kinase (PKM2).
262 tively express the less active M2 isoform of pyruvate kinase (PKM2).
263 a double mutant in two isoforms of plastidic pyruvate kinase (pkpbeta(1)pkpalpha; At5g52920 and At3g2
264 f interleukin-3, suggesting that the nuclear pyruvate kinase plays an important role in cell prolifer
265 axoneme, whereas phosphoglycerate mutase and pyruvate kinase primarily reside in the detergent-solubl
266          Overexpression of the M2 isoform of pyruvate kinase protein fused with a nuclear localizatio
267 tation and were associated with the red-cell pyruvate kinase protein level at baseline.
268 ously established consequences of abolishing pyruvate kinase (Pyk) activity in Escherichia coli durin
269                                              Pyruvate kinase (PYK) is an essential glycolytic enzyme
270                                              Pyruvate kinase (PYK) is an essential glycolytic enzyme
271  different conformers of the same species of pyruvate kinase (PYK).
272 olysis and theMtbgenome harbors one putative pyruvate kinase (pykA, Rv1617).
273 on aldehyde-alcohol dehydrogenase (AdhE) and pyruvate kinase (PykF) enzymes, previously not known to
274 t allosteric regulation of the activities of pyruvate kinase (PykF, but not PykA), phosphofructokinas
275 eptide antibodies established that cytosolic pyruvate kinase (PyrKinc) is phosphorylated at both site
276 operation of the phosphoglycerate kinase and pyruvate kinase reactions to enzymatically generate ATP.
277  GAPDH, aldolase, lactate dehydrogenase, and pyruvate kinase revealed not only the anticipated bindin
278 ibility of this approach using rabbit muscle pyruvate kinase (rM1-PK) which catalyzes the conversion
279 NA ends, 2-phospho-L-lactate is a product of pyruvate kinase side reaction, and both potently inhibit
280 uvate kinase activity and an increase in the pyruvate kinase substrate phosphoenolpyruvate.
281 s is demonstrated by the ability of GAPDH or pyruvate kinase substrates to directly block the K(ATP)
282 l C-terminal truncation to generate a 51 kDa pyruvate kinase subunit which might have altered regulat
283  dynamic movement of the holo form traps the pyruvate kinase tetramer in its enzymatically active sta
284       Here we show thatpykAencodes an active pyruvate kinase that is allosterically activated by gluc
285          These fluxes changed with plastidic pyruvate kinase to maintain a supply of pyruvate for ami
286                                   Fusions of pyruvate kinase to the lentiviral integrases did not rev
287 ntitative HTS (qHTS), tested with the enzyme pyruvate kinase, to generate concentration-response curv
288 d activation of fructose-1,6-bisphosphate on pyruvate kinase translate flux information into the conc
289 are proposed to explain how Escherichia coli pyruvate kinase type 1 is allosterically regulated: the
290 our cell exosomes secretion is controlled by pyruvate kinase type M2 (PKM2), which is upregulated and
291 versible aggregation of the metabolic enzyme pyruvate kinase under environmental stress and propose a
292 vely, fructose 1,6-bisphosphate aldolase and pyruvate kinase, under the same conditions.
293 d nuclear translocation of the M2 isoform of pyruvate kinase was dependent on the activation of Jak2.
294 hosphate isomerase was up-regulated, whereas pyruvate kinase was down-regulated.
295           In addition, the glycolytic enzyme pyruvate kinase was found to be phosphorylated by PrkD o
296            The C domain of the M2 isoform of pyruvate kinase was sufficient for interleukin-3-induced
297 peroxide dismutase and the glycolytic enzyme pyruvate kinase were deficient in an mntH strain grown u
298 r neurons express AGC1 and the M2 isoform of pyruvate kinase, which is commonly associated with aerob
299  monovalent cation with wild type (WT) yeast pyruvate kinase (YPK) and with the T298S, T298C, and T29
300        The active site T298 residue of yeast pyruvate kinase (YPK), located in a position to serve po

 
Page Top